Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Patient Who Became Acutely Ill after Stopping Anti-HIV Treatment
19 September 2000 | Volume 133 Issue 6 | Page I-46
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician.
The summary below is from the full report titled "Recurrence of the Acute HIV Syndrome after Interruption of Antiretroviral Therapy in a Patient with Chronic HIV Infection: A Case Report." It is in the 19 September 2000 issue of Annals of Internal Medicine (volume 131, pages 435-438). The authors are JM Kilby, PA Goepfert, AP Miller, JW Gnann Jr., M Sillers, MS Saag, and RP Bucy.
What is the problem and what is known about it so far?
![]()
Antiretroviral (anti-HIV) therapy consists of combinations of drugs that slow the growth of the virus. Two laboratory tests, CD4 cell count and viral load, help to monitor patients' response to anti-HIV treatment. CD4 count is a measure of immune cells; high CD4 counts are better than low ones. The viral load is the amount of the virus's genetic material in a person's blood; the lower the viral load, the better. It is well known that the virus starts multiplying rapidly throughout the body when an HIV-infected person stops anti-HIV therapy, causing the viral load in the bloodstream to increase. However, an acute illness has not been described in this setting.
Why did the researchers do this particular study?
![]()
To describe a patient who became acutely ill after stopping anti-HIV treatment.
Who was studied?
![]()
An adult man with HIV infection.
How was the study done?
![]()
The researchers described the clinical course, including CD4 cell count and viral load, before and after the patient stopped anti-HIV therapy. They also described studies that they did to rule out other possible causes of the illness.
What did the researchers find?
![]()
The patient stopped anti-HIV medicines shortly after receiving a shot of influenza (flu) vaccine. Eleven days later, he became ill with fever, muscle aches, fatigue, swollen lymph nodes, vomiting, and diarrhea. These symptoms are very similar to those that affect many people when they are first infected with HIV. The patient's CD4 count decreased from 743 to 164 cells per cubic millimeter. Viral load increased to 327,874 copies per milliliter from a previous level of less than 50 copies per milliliter. Tests did not identify any other cause of the illness. About 3 weeks later, the patient resumed anti-HIV medicines and his symptoms rapidly resolved. Within the next 2 weeks, the viral load decreased to 2743 copies per milliliter and the CD4 cell count increased to more than 500 cells per cubic millimeter.
What were the limitations of the study?
![]()
This report describes only one patient, so it can't tell us how frequently this kind of acute illness occurs when anti-HIV treatment is stopped. The relationship of the flu vaccine to the illness is uncertain, although flu vaccination does not usually cause symptoms such as these in HIV-infected persons.
What are the implications of the study?
![]()
It seems that an illness similar to that seen with initial HIV infection, along with a rapid increase in the amount of virus in the blood, can occur with the discontinuation of anti-HIV treatment. Doctors and patients should be aware that this syndrome might occur when patients stop anti-HIV drugs.
Related articles in Annals:
This article has been cited by other articles:
![]() |
A. Boschi, C. Tinelli, P. Ortolani, and M. Arlotti Safety and factors predicting the duration of first and second treatment interruptions guided by CD4+ cell counts in patients with chronic HIV infection J. Antimicrob. Chemother., March 1, 2006; 57(3): 520 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Prado, A. Shintani, M. Bofill, B. Clotet, L. Ruiz, and J. Martinez-Picado Lack of Longitudinal Intrapatient Correlation between p24 Antigenemia and Levels of Human Immunodeficiency Virus (HIV) Type 1 RNA in Patients with Chronic HIV Infection during Structured Treatment Interruptions J. Clin. Microbiol., April 1, 2004; 42(4): 1620 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-M. Roger, J. Durant, M. Ticchioni, P. Halfon, J.-P. Breittmayer, C. Brignone, S. Chaillou, B. Dunais, P. Dellamonica, A. Bernard, et al. Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions J. Antimicrob. Chemother., August 1, 2003; 52(2): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. L. Abbas and J. W. Mellors Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward PNAS, October 15, 2002; 99(21): 13377 - 13378. [Full Text] [PDF] |
||||
![]() |
D. V. Havlir Structured intermittent treatment for HIV disease: Necessary concession or premature compromise? PNAS, January 8, 2002; 99(1): 4 - 6. [Full Text] [PDF] |
||||
![]() |
Retroviral Rebound Journal Watch (General), October 10, 2000; 2000(1010): 2 - 2. [Full Text] |
||||
![]() |
G. M. Ortiz, M. Wellons, J. Brancato, H. T. T. Vo, R. L. Zinn, D. E. Clarkson, K. Van Loon, S. Bonhoeffer, G. D. Miralles, D. Montefiori, et al. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects PNAS, November 6, 2001; 98(23): 13288 - 13293. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||